Jeremiah R Brown1, Chirag R Parikh2, Cathy S Ross3, Robert S Kramer4, Patrick C Magnus3, Kristine Chaisson5, Richard A Boss5, Robert E Helm6, Susan R Horton7, Patricia Hofmaster8, Helen Desaulniers9, Pamela Blajda9, Benjamin M Westbrook9, Dennis Duquette6, Kelly LeBlond7, Reed D Quinn4, Cheryl Jones5, Anthony W DiScipio10, David J Malenka3. 1. Departments of Medicine Section of Cardiology and Community and Family Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Electronic address: jbrown@dartmouth.edu. 2. Program of Applied Translational Research, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 3. Departments of Medicine Section of Cardiology and Community and Family Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. 4. Department of Surgery, Maine Medical Center, Portland, Maine. 5. Department of Surgery, Concord Hospital, Concord, New Hampshire. 6. Department of Surgery, Portsmouth Regional Hospital, Portsmouth, New Hampshire. 7. Central Maine Heart and Vascular Center, Central Maine Medical Center, Lewiston, Maine. 8. Department of Surgery, Eastern Maine Medical Center, Bangor, Maine. 9. Department of Surgery, Catholic Medical Center, Manchester, New Hampshire. 10. Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Abstract
BACKGROUND: Of patients undergoing cardiac surgery in the United States, 15% to 20% are re-hospitalized within 30 days. Current models to predict readmission have not evaluated the association between severity of postoperative acute kidney injury (AKI) and 30-day readmissions. METHODS: We collected data from 2,209 consecutive patients who underwent either coronary artery bypass or valve surgery at 7 member hospitals of the Northern New England Cardiovascular Disease Study Group Cardiac Surgery Registry between July 2008 and December 2010. Administrative data at each hospital were searched to identify all patients readmitted to the index hospital within 30 days of discharge. We defined AKI stages by the AKI Network definition of 0.3 or 50% increase (stage 1), twofold increase (stage 2), and a threefold or 0.5 increase if the baseline serum creatinine was at least 4.0 (mg/dL) or new dialysis (stage 3). We evaluate the association between stages of AKI and 30-day readmission using multivariate logistic regression. RESULTS: There were 260 patients readmitted within 30 days (12.1%). The median time to readmission was 9 (interquartile range, 4 to 16) days. Patients not developing AKI after cardiac surgery had a 30-day readmission rate of 9.3% compared with patients developing AKI stage 1 (16.1%), AKI stage 2 (21.8%), and AKI stage 3 (28.6%, p < 0.001). Adjusted odds ratios for AKI stage 1 (1.81; 1.35, 2.44), stage 2 (2.39; 1.38, 4.14), and stage 3 (3.47; 1.85 to 6.50). Models to predict readmission were significantly improved with the addition of AKI stage (c-statistic 0.65, p = 0.001) and net reclassification rate of 14.6% (95% confidence interval: 5.05% to 24.14%, p = 0.003). CONCLUSIONS: In addition to more traditional patient characteristics, the severity of postoperative AKI should be used when assessing a patient's risk for readmission.
BACKGROUND: Of patients undergoing cardiac surgery in the United States, 15% to 20% are re-hospitalized within 30 days. Current models to predict readmission have not evaluated the association between severity of postoperative acute kidney injury (AKI) and 30-day readmissions. METHODS: We collected data from 2,209 consecutive patients who underwent either coronary artery bypass or valve surgery at 7 member hospitals of the Northern New England Cardiovascular Disease Study Group Cardiac Surgery Registry between July 2008 and December 2010. Administrative data at each hospital were searched to identify all patients readmitted to the index hospital within 30 days of discharge. We defined AKI stages by the AKI Network definition of 0.3 or 50% increase (stage 1), twofold increase (stage 2), and a threefold or 0.5 increase if the baseline serum creatinine was at least 4.0 (mg/dL) or new dialysis (stage 3). We evaluate the association between stages of AKI and 30-day readmission using multivariate logistic regression. RESULTS: There were 260 patients readmitted within 30 days (12.1%). The median time to readmission was 9 (interquartile range, 4 to 16) days. Patients not developing AKI after cardiac surgery had a 30-day readmission rate of 9.3% compared with patients developing AKI stage 1 (16.1%), AKI stage 2 (21.8%), and AKI stage 3 (28.6%, p < 0.001). Adjusted odds ratios for AKI stage 1 (1.81; 1.35, 2.44), stage 2 (2.39; 1.38, 4.14), and stage 3 (3.47; 1.85 to 6.50). Models to predict readmission were significantly improved with the addition of AKI stage (c-statistic 0.65, p = 0.001) and net reclassification rate of 14.6% (95% confidence interval: 5.05% to 24.14%, p = 0.003). CONCLUSIONS: In addition to more traditional patient characteristics, the severity of postoperative AKI should be used when assessing a patient's risk for readmission.
Authors: Keyvan Karkouti; Duminda N Wijeysundera; Terrence M Yau; Jeannie L Callum; Davy C Cheng; Mark Crowther; Jean-Yves Dupuis; Stephen E Fremes; Blaine Kent; Claude Laflamme; Andre Lamy; Jean-Francois Legare; C David Mazer; Stuart A McCluskey; Fraser D Rubens; Corey Sawchuk; W Scott Beattie Journal: Circulation Date: 2009-01-19 Impact factor: 29.690
Authors: Jeremiah R Brown; Richard P Cochran; Todd A MacKenzie; Anthony P Furnary; Karyn S Kunzelman; Cathy S Ross; Craig W Langner; David C Charlesworth; Bruce J Leavitt; Lawrence J Dacey; Robert E Helm; John H Braxton; Robert A Clough; Robert F Dunton; Gerald T O'Connor Journal: Ann Thorac Surg Date: 2008-07 Impact factor: 4.330
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Joshua M Rosenblum; Brendan P Lovasik; John C Hunting; Jose Binongo; Michael E Halkos; Bradley G Leshnower; Jeffrey S Miller; Omar M Lattouf; Robert A Guyton; William B Keeling Journal: Gen Thorac Cardiovasc Surg Date: 2019-02-08
Authors: Jeremiah R Brown; Heather Thiessen-Philbrook; Christine A Goodrich; Andrew R Bohm; Shama S Alam; Steven G Coca; Eric McArthur; Amit X Garg; Chirag R Parikh Journal: Ann Thorac Surg Date: 2019-03-14 Impact factor: 4.330
Authors: Anne D Cherry; Jennifer N Hauck; Benjamin Y Andrew; Yi-Ju Li; Jamie R Privratsky; Lakshmi D Kartha; Alina Nicoara; Annemarie Thompson; Joseph P Mathew; Mark Stafford-Smith Journal: J Clin Anesth Date: 2019-11-04 Impact factor: 9.452
Authors: Allen D Everett; Shama S Alam; Sherry L Owens; Devin M Parker; Christine Goodrich; Donald S Likosky; Heather Thiessen-Philbrook; Moritz Wyler von Ballmoos; Kevin Lobdell; Todd A MacKenzie; Jeffrey Jacobs; Chirag R Parikh; Anthony W DiScipio; David J Malenka; Jeremiah R Brown Journal: J Extra Corpor Technol Date: 2019-12
Authors: Jeremiah R Brown; Jeffrey P Jacobs; Shama S Alam; Heather Thiessen-Philbrook; Allen Everett; Donald S Likosky; Kevin Lobdell; Moritz C Wyler von Ballmoos; Devin M Parker; Amit X Garg; Todd Mackenzie; Marshall L Jacobs; Chirag R Parikh Journal: Ann Thorac Surg Date: 2018-08-04 Impact factor: 4.330
Authors: Jeremiah R Brown; William M Hisey; Emily J Marshall; Donald S Likosky; Elizabeth L Nichols; Allen D Everett; Sara K Pasquali; Marshall L Jacobs; Jeff P Jacobs; Chirag R Parikh Journal: Ann Thorac Surg Date: 2016-06-17 Impact factor: 4.330
Authors: Jamie R Privratsky; Yi-Ju Li; Carol Haynes; Mihai Podgoreanu; Joseph Mathew; Svati H Shah; Mark Stafford-Smith Journal: J Cardiothorac Vasc Anesth Date: 2020-05-11 Impact factor: 2.628